Analytical performance of time-resolved fluorometry-based Innotrac Aio!™ cardiac marker immunoassays

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 63, Issue 1, 2003, Pages 55-64

  Hedberg, Pirjo ^a   Valkama, J ^a   Puukka, M ^a  

^a OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Creatine kinase MB; Myocardial infarction; Myoglobin; Point of care testing; Troponin I

Indexed keywords

CREATINE KINASE MB; EDETIC ACID; HEPARIN DERIVATIVE; LITHIUM; MYOGLOBIN; REAGENT; TROPONIN I;

ACCURACY; ANALYTIC METHOD; ARTICLE; BLOOD; CARDIAC MARKER IMMUNOASSAY; CHEMISTRY; CORONARY CARE UNIT; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; EMERGENCY WARD; FLUOROMETRY; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; LABORATORY; MAJOR CLINICAL STUDY; PLASMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ROOM TEMPERATURE;

EID: 0346774828     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365510310000493     Document Type: Article

References (18)

1. Meinertz T, Hamm CW. Rapid testing for cardiac troponins in patients with acute chest pain in the emergency room. Eur Heart J 1998; 19: 973-4.
2. Roth A, Malov N, Bloch Y, Golovner M, Slesarenko Y, Naveh R, Kaplinsky E, Laniado S. Assessment of a creatinine kinase-MB/myoglobin kit in the prehospital setting in patients presenting with acute nontraumatic chest pain: the "shahal" experience. Crit Care Med 1999; 27: 1085-9.
3. Pettersson K, Katajamäki T, Irjala K, Leppänen V, Majamaa-Voltti K, Laitinen P. Time-resolved fluorometry (TRF)-based immunoassay concept for rapid and quantitative determination of biochemical myocardial infarction markers from whole blood, serum and plasma. Luminescence 2000; 15: 1-9.
4. Lövgren T, Meriö L, Mitrunen K, Mäkinen ML, Mäkelä M, Blomberg K, Palenius T, Pettersson K. One-step all-in-one dry reagent immunoassays using a fluorescent Europium chelate label and time-resolved fluorometry. Clin Chem 1996; 42: 1196-201.
5. Hedberg P, Valkama J, Puukka M. Evaluation of a rapid Innotrac Aio! immunoanalyzer for quantification of cardiac markers. Clin Chem Lab Med 2001; 39 Suppl. PO-S007: 331.
6. Panteghini M, Pagani F. Biological variation of myoglobin in serum. Clin Chem 1997; 43: 2435.
7. Hedberg P, Melkko T, Valkama J, Puukka M. Higher CK-MB mass value in heparin plasma than in serum measured with the Abbott AxSYM system. Clin Chem Lab Med 2001; 39: 872-4.
8. Price A, Burgin C, Cruise M. Stability of cardiac troponin and CK-MB mass isoenzyme. Clin Chem Lab Med 2000; 38: 1159-60.
9. Katrukha A, Bereznikova A, Filatov V, Esakova T, Kolosova O, Pettersson K, Lövgren T, Bulargina T, Trifonov I, Gratsiansky N, Pulkki K, Voipio-Pulkki LM, Gusev N. Degradation of cardiac troponin I: implication for reliable immuno-detection. Clin Chem 1998; 44: 2433-40.
10. Wu A, Apple F, Gibler W, Jesse R, Warshaw M, Valdes R Jr. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for use of cardiac markers in coronary artery diseases. Clin Chem 1999; 45: 1104-21.
11. Panteghini M, Apple F, Christenson R, Dati F, Mair J, Wu A. Use of biochemical markers in acute coronary syndromes: IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage. Clin Chem Lab Med 1999; 37: 687-93.
12. The Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined-A consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-69.
13. Braunwald E, Antman E, Beasley J, Califf R, Cheitlin M, Hochman J, Jones R, Kereiakes D, Kupersmith J. ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). Circulation 2000; 102: 1193-209.
14. Ross SM, Fraser CG. Biological variation of cardiac markers: analytical and clinical considerations. Ann Clin Biochem 1998; 35: 80-4.
15. Dasgupta A, Banerjee SK, Datta PFalsehyphen-positivetroponin. I in the MEIA due to the presence of rheumatoid factors in serum. Elimination of this interference by using a polyclonal antisera against rheumatoid factors. Am J Clin Pathol 1999; 112: 753-6.
16. Zaman Z, De Spiegeleer S, Gerits M, Blanckaert N. Analytical and clinical performance of two cardiac troponin I immunoassays. Clin Chem Lab Med 1999; 37: 889-97.
17. Quinn-Hall K, Bateman S, Wu A, Wieczorek S, Ficher G, Yeo K. Functional sensitivity of cardiac troponin assays and implications for risk stratification (Abstract). Clin Chem 2000; 46: A78.
18. Hamm C, Goldmann B, Heeshen C, Kreymann G, Berger J, Meinertz T. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997; 337: 1648-53.